182 related articles for article (PubMed ID: 35900175)
1. Acute and Chronic Effects of Adjuvant Therapy on Inflammatory Markers in Breast Cancer Patients.
Bower JE; Ganz PA; Irwin MR; Cole SW; Carroll J; Kuhlman KR; Petersen L; Garet D; Asher A; Hurvitz SA; Crespi CM
JNCI Cancer Spectr; 2022 Jul; 6(4):. PubMed ID: 35900175
[TBL] [Abstract][Full Text] [Related]
2. Inflammation-related proteins as biomarkers of treatment-related behavioral symptoms: A longitudinal study of breast cancer patients and age-matched controls.
Patel SK; Breen EC; Paz IB; Kruper L; Mortimer J; Wong FL; Bhatia S; Irwin MR; Behrendt CE
Brain Behav Immun Health; 2023 Oct; 32():100670. PubMed ID: 37637432
[TBL] [Abstract][Full Text] [Related]
3. Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?
Ganz PA; Bower JE; Kwan L; Castellon SA; Silverman DH; Geist C; Breen EC; Irwin MR; Cole SW
Brain Behav Immun; 2013 Mar; 30 Suppl(Suppl):S99-108. PubMed ID: 22884417
[TBL] [Abstract][Full Text] [Related]
4. Systemic release of soluble TNF receptors after high-dose TNF in isolated limb perfusion.
Gérain J; Liénard D; Pampallona S; Baumgartner M; Rüegg C; Buurman WA; Eggermont A; Lejeune F
Cytokine; 1997 Dec; 9(12):1034-42. PubMed ID: 9417816
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?
Bower JE; Ganz PA; Irwin MR; Kwan L; Breen EC; Cole SW
J Clin Oncol; 2011 Sep; 29(26):3517-22. PubMed ID: 21825266
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of serum soluble tumour necrosis factor receptor (TNF-R) type-I and type-II after a single interferon-alpha (IFN-alpha) injection in chronic hepatitis C.
Fabris C; Del Forno M; Falleti E; Toniutto P; Pirisi M
Clin Exp Immunol; 1999 Sep; 117(3):556-60. PubMed ID: 10469062
[TBL] [Abstract][Full Text] [Related]
7. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG
Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-10 upregulates tumor necrosis factor receptor type-II (p75) gene expression in endotoxin-stimulated human monocytes.
Dickensheets HL; Freeman SL; Smith MF; Donnelly RP
Blood; 1997 Nov; 90(10):4162-71. PubMed ID: 9354687
[TBL] [Abstract][Full Text] [Related]
9. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
Tesar V; Jirsa M; Masek Z; Bartůnková J; Stejskalová A; Dostál C; Zabka J; Chábová V; Rysavá R
Cas Lek Cesk; 1998 May; 137(9):271-5. PubMed ID: 9650355
[TBL] [Abstract][Full Text] [Related]
10. Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB.
Tsao TC; Li L; Hsieh M; Liao S; Chang KS
Eur Respir J; 1999 Sep; 14(3):490-5. PubMed ID: 10543265
[TBL] [Abstract][Full Text] [Related]
11. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis.
Tsao TC; Hong Jh; Li LF; Hsieh MJ; Liao SK; Chang KS
Chest; 2000 Jan; 117(1):103-9. PubMed ID: 10631206
[TBL] [Abstract][Full Text] [Related]
12. Effects of Probiotic Supplementation on Immune and Inflammatory Markers in Athletes: A Meta-Analysis of Randomized Clinical Trials.
Guo YT; Peng YC; Yen HY; Wu JC; Hou WH
Medicina (Kaunas); 2022 Aug; 58(9):. PubMed ID: 36143865
[No Abstract] [Full Text] [Related]
13. IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes.
Joyce DA; Steer JH
Cytokine; 1996 Jan; 8(1):49-57. PubMed ID: 8742066
[TBL] [Abstract][Full Text] [Related]
14. Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis.
Comabella M; Julià E; Tintoré M; Brieva L; Téllez N; Río J; López C; Rovira A; Montalban X
J Neurol; 2008 Aug; 255(8):1136-41. PubMed ID: 18484235
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer.
Patel SK; Wong AL; Wong FL; Breen EC; Hurria A; Smith M; Kinjo C; Paz IB; Kruper L; Somlo G; Mortimer JE; Palomares MR; Irwin MR; Bhatia S
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26101331
[TBL] [Abstract][Full Text] [Related]
16. Soluble cytokine receptors in renal vasculitis and lupus nephritis.
Tesar V; Jirsa M; Zima T; Kalousová M; Bartunková J; Stejskalová A; Dostál C; Zabka J
Med Sci Monit; 2002 Jan; 8(1):BR24-9. PubMed ID: 11782670
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Schenk JM; Kristal AR; Neuhouser ML; Tangen CM; White E; Lin DW; Kratz M; Thompson IM
Am J Epidemiol; 2010 Mar; 171(5):571-82. PubMed ID: 20142396
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of aging associated with past treatments in breast cancer survivors.
Scuric Z; Carroll JE; Bower JE; Ramos-Perlberg S; Petersen L; Esquivel S; Hogan M; Chapman AM; Irwin MR; Breen EC; Ganz PA; Schiestl R
NPJ Breast Cancer; 2017; 3():50. PubMed ID: 29238750
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the release of tumour necrosis factor (TNF)alpha and soluble TNF receptor by gamma irradiation and interferon gamma in Ewing's sarcoma/peripheral primitive neuroectodermal tumour cells.
van Valen F; Kentrup-Lardong V; Truckenbrod B; Rübe C; Winkelmann W; Jürgens WW
J Cancer Res Clin Oncol; 1997; 123(5):245-52. PubMed ID: 9201246
[TBL] [Abstract][Full Text] [Related]
20. Pre-treatment levels of inflammatory markers and chemotherapy completion rates in patients with early-stage breast cancer.
Schauer T; Henriksson A; Strandberg E; Lindman H; Berntsen S; Demmelmaier I; Raastad T; Nordin K; Christensen JF
Int J Clin Oncol; 2023 Jan; 28(1):89-98. PubMed ID: 36269530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
